Primary ACL Reconstruction in Patient Over 40 Years: Allograft Versus Autograft
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorUniversità Vita-Salute San Raffaele
About this trial
The aim of this study is to investigate the differences in graft failure between patients that underwent ACL reconstruction using allograft tendons and patients that underwent ACL reconstruction using autograft tendons in patients older than 40 y.o. and after at least 2 years of follow-up. The hypothesis of the study is that there will be a difference in graft failure and patient reported functional outcomes between allograft and autograft ACL reconstruction.
Eligibility criteria
Qualifiers
Participant is willing and able to give informed consent for participation in the study.
Male and female patients of fertile age can be recruited
Patients aged 40 years old and above, and 2 years minimum of follow-up
Patients that underwent primary ACL reconstruction with allograft an autograft tendons
Disqualifiers
Multiligamentous lesion
Meniscal tear leading to subtotal or total meniscectomy or meniscal graft
Indication for major cartilage restoration or resurfacing
Ipsilateral knee fractures
Trial design
Treatments tested in this trial
- ACL reconstruction
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
1IRCCS Ospedale San Raffaele20132, MilanMilano, Italy
Sponsors and collaborators
Università Vita-Salute San Raffaele
Lead sponsor
IRCCS Ospedale San Raffaele
Sponsor institution
Source ClinicalTrials.gov